In a recent development, it has been revealed that China's drugmakers are currently unable to sell mRNA vaccines. Despite this setback, these companies have not given up on their efforts to develop and distribute these innovative shots.
Messenger RNA (mRNA) vaccines have gained significant attention due to their effectiveness in combating the COVID-19 virus. However, Chinese drugmakers are facing regulatory hurdles that prevent them from selling these vaccines in the market.